| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0048 | 1 |